The Primary Question for LCT is "what is the plan after May 2018?"
My belief is that the data will provide and strong indication that the LCT Treatment NTcell may well halt the progression of Parkinson Disease.
The fundamental question is how will LCT commercialise this Technology, where are the dollars generated?, when will the dollars be generated? and How Much ?
Will any Royalties be paid to LCT from Diabecell in the immediate future? what happens to DOL if LCT cannot continue?
LCT as a company don't seemed to have learnt a thing about Shareholder updates, Market Updates and Paid Investor Content. They have effectively now held the shareholders investment funds for 12 years with no income or revenue from products or services? and have no business plan involving return of investment that the SH are aware of?
as Whytee says , we can Only But Wait and See.
LCT Price at posting:
2.9¢ Sentiment: Hold Disclosure: Held
